Policy

Rep. Greg Murphy, MD, (R-NC), discusses reforms he hopes Congress will consider this year.

Clinical and preclinical are distinctions that could guide patient treatment, public health and medical policy going forward, according to study commission.

Rep. Greg Murphy, MD (R-North Carolina), discusses reforms he hopes Congress will consider this year.

A new West Health-Gallup survey found that nearly half of Americans believe the country is headed in the wrong direction regarding health care costs.

Rep. Greg Murphy, MD (R-North Carolina), discusses reforms he hopes Congress will consider this year.

Economists expect Fed to pause rate cuts in the short term

Rep. Greg Murphy, MD (R-North Carolina), discusses reforms he hopes Congress will consider this year.

Data from the recent AMGA 2024 Medical Group Operations and Finance Survey reveal medical groups continue to face challenges related to providing quality, cost-effective care in a constantly evolving health care environment.

Evidence is uncertain about effectiveness of screening in men.

Study finds traditional Medicare doing just as well at providing dental, vision and hearing services

Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, discusses the Trump administration's likely approach to health care.

Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, talks about how the Trump administration is more experienced this time around.

A policy scenario to lower nicotine in tobacco products was published during the first Trump administration. FDA may be poised to bring it back for more consideration.

$3.9 million grant intended to boost primary care and help rural areas in the state

New perspective calls for regulatory reforms to address the rising trend of physician strikes in the U.S. based on international examples.

Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, advises primary care physicians on how to best navigate potential health care shifts under the Trump administration.

Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, talks about significant long-term implications of the Trump administration's approach to health care policy.

Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, explains how the Trump administration could work together, or clash, with Congress on health care legislation during their next term.

A Weill Cornell Medicine study found that one-third of all Medicare Part D pharmacy spending and nearly 40% of specialty drug spending within Medicare Part D was through pharmacies owned by the four largest PBMs: CVS, UnitedHealth Group, Cigna and Humana.

Financial sustainability of some hospitals comes into question

Steady monthly growth was even with 2023, according to latest figures from Bureau of Labor Statistics.

Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, explains how the Trump administration might approach drug pricing policy.

Two companies highlighted in bipartisan review of ‘detrimental effects of PE ownership on hospitals and their patients.’

Opting out of Medicare might be your only choice

With time still left to enroll, the 2025 marketplace open enrollment period has seen 11.6 million more enrollees compared to 2021.